Transcript Slide 1

Academic Inventions through
Multidisciplinary Collaborations
between Weill Cornell Medical
College and Ithaca Campuses
Bo Liu
Division of Vascular Surgery
Translate inventions in material science to
novel treatments for vascular diseases.
Vascular Surgeons
Experimental hypotheses
Material Scientists
Vascular Biologists
Project I: DNA Carriers
Problem: Lack of safe and efficient
DNA/RNA carriers for molecular therapy.
O
*
O
x
O
H
N
H
C
C
O
O
O
y
C
NH
Hypothesis: Newly invented PEA polymers
are capable of binding DNA and delivering it
to vascular cells and tissues.
H2 N
H
C
H
N
*
NH
NH2
H2 N
NH2
PEA polymer
Cornell University Seed Grant (Liu & Chu)
11/1/06-10/31/07
Novel biodegradable biomaterials as non-viral gene transfer systems.
Cytotoxicity
healthy
SMC
15 μg PEA
1,500 μg PEA
Control – no transfection
unhealthy
15 μg PEI
15 μg Superfect®
Higher %, more cell friendly
Cytotoxicity: Cell Viability
Transfection Efficiency in SMC
RLU/mg
Firefly
4.5E+05
4.0E+05
3.5E+05
3.0E+05
2.5E+05
2.0E+05
1.5E+05
1.0E+05
5.0E+04
0.0E+00
SF
2-A-6E-Cl100
2-A-6E-Cl200
Commercial reagent
2-A-6E-Cl500
2-A-6E-Cl-1K 2-A-6E-Cl-2K
Chu’s PEA samples
SMC Transfection by DNA Encoded with
Green Fluorescence Protein
Outcome: grant proposals

NIH R21/R33 submitted on 9/16/07
Novel biodegradable polymers as non-viral gene
transfer systems.
Liu, Kent, Rafii, and Chu

The Uehara Memorial Foundation (Japan)
Research Fellowship----- 1/01/08 to 12/31/09
Yamanochi
Outcome: publication
Transfection of Vascular Smooth Muscle Cells with Novel
Biodegradable Arginine Based Poly(ester-amide)s
Dai Yamanouchi, M.D., Ph.D.,1, Jun Wu,2, Andrew Lazar,1, K Craig Kent,
MD.,1, Chih-Chang Chu, Ph.D.,2, Bo Liu, Ph.D.1.
1.
Weill Medical College; 2. Cornell University
Submitted to Molecular Therapy
Project II: Tissue engineering of blood vessels
Problem: Synthetic arterial grafts fail
due to restenosis.
Approach: Using biodegradable
materials as scaffold to generate
blood vessels ex vivo or in vitro.
Morgan Seed Grant (Chu, Peinhart-King, Liu, and Kent)
7/1/07-12/31/08
Novel biodegradable scaffolds for tissue engineering of blood
vessels.
Chu: Human Ecology
Synthesis of PEA-based biodegradable and
biofunctional elastomeric scaffolds
Feedback for
optimization of design
parameters
Reinhart-King: BME
Liu/Kent: Weill Medical
In vitro engineering of scaffolds
& cell adhesion study using
vascular cells
Optimization using stem-cell
mediated healing to enhance success
of engineered grafts
Liu/Kent: Weill Medical
In vivo animal model & implantation
Future Plan

NIH: PAR-06-504 (R01)
Enabling Technologies for Tissue Engineering and
Regenerative Medicine
Projected submission date: 9/10/08

Industry grants

Patents
Vascular Surgery Lab
K. Craig Kent, MD
Bo Liu, PhD
Rachel Elden
Brad Herman, PhD
Kaori Kato, MD
Rishi Kundi, MD
Sebastian Schuble, MD
Shirling Tsai, MD
Chunjie Wang
Dai Yamanouchi, MD, PhD
Fan Zhang, MD, PhD
Andrew Zohlman
Ithaca
C.C. Chu, PhD
Hua Song, PhD
Jun Wu
Department of Surgery
Research and Sponsored Program
Caren A Heller, MD
Cornell Intercampus Seed Grant
Morgan Seed grant